Franklin Resources’s Oruka Therapeutics ORKA Stock Holding History

Franklin Resources’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$154M	Buy	1,621,451 +617,395	+61%	+$41.1M	0.03%	360
2026 Q1	$49.2M	Buy	1,004,056 +65,635	+7%	+$2.28M	0.01%	654
2025 Q4	$28.4M	Sell	938,421 -127,361	-12%	-$3.55M	0.01%	839
2025 Q3	$20.5M	Buy	1,065,782 +52,814	+5%	+$783K	0.01%	947
2025 Q2	$11.4M	Buy	1,012,968 +292,421	+41%	+$3.05M	﹤0.01%	1088
2025 Q1	$7.39M	Hold	720,547	–	–	﹤0.01%	1206
2024 Q4	$14M	Hold	720,547	–	–	﹤0.01%	1010
2024 Q3	$20M	Buy	+720,547	New	+$25.1M	0.01%	896
2018 Q1	–	Sell	-5,634	Closed	-$1.67M	–	1554
2017 Q4	$1.67M	Hold	5,634	–	–	﹤0.01%	1248
2017 Q3	$1.34M	Hold	5,634	–	–	﹤0.01%	1262
2017 Q2	$2.98M	Hold	5,634	–	–	﹤0.01%	1172
2017 Q1	$3.04M	Hold	5,634	–	–	﹤0.01%	1181
2016 Q4	$3.47M	Hold	5,634	–	–	﹤0.01%	1148
2016 Q3	$3.52M	Hold	5,634	–	–	﹤0.01%	1168
2016 Q2	$3.53M	Hold	5,634	–	–	﹤0.01%	1155
2016 Q1	$4.17M	Hold	5,634	–	–	﹤0.01%	1130
2015 Q4	$5.66M	Hold	5,634	–	–	﹤0.01%	1110
2015 Q3	$6.05M	Hold	5,634	–	–	﹤0.01%	1109
2015 Q2	$8.82M	Buy	+5,634	New	+$7.41M	﹤0.01%	1064

Other funds holding ORKA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Franklin Resources's ORKA Position: Q2 2026 in Review

Franklin Resources increased its Oruka Therapeutics (ORKA) stake by 61% in Q2 2026, buying an estimated $41.1M and bringing the position to 1,621,451 shares worth $154M. The position accounts for 0.03% of the portfolio, ranked #360.

Franklin Resources first reported a position in ORKA in Q2 2015 and has held it in 19 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

Franklin Resources held 1,621,451 shares of Oruka Therapeutics worth $154M as of Q2 2026.
Franklin Resources bought 617,395 Oruka Therapeutics shares in Q2 2026, an estimated $41.1M.
Oruka Therapeutics made up 0.03% of Franklin Resources's portfolio in Q2 2026, its #360 holding.
Franklin Resources first reported a position in Oruka Therapeutics in Q2 2015 and has held it in 19 quarters since.
256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.